Cite
KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia.
MLA
Xu, Xin, et al. “KDM3B Shows Tumor-Suppressive Activity and Transcriptionally Regulates HOXA1 through Retinoic Acid Response Elements in Acute Myeloid Leukemia.” Leukemia & Lymphoma, vol. 59, no. 1, Jan. 2018, pp. 204–13. EBSCOhost, https://doi.org/10.1080/10428194.2017.1324156.
APA
Xu, X., Nagel, S., Quentmeier, H., Wang, Z., Pommerenke, C., Dirks, W. G., Macleod, R. A. F., Drexler, H. G., & Hu, Z. (2018). KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia. Leukemia & Lymphoma, 59(1), 204–213. https://doi.org/10.1080/10428194.2017.1324156
Chicago
Xu, Xin, Stefan Nagel, Hilmar Quentmeier, Zhanju Wang, Claudia Pommerenke, Wilhelm G. Dirks, Roderick A. F. Macleod, Hans G. Drexler, and Zhenbo Hu. 2018. “KDM3B Shows Tumor-Suppressive Activity and Transcriptionally Regulates HOXA1 through Retinoic Acid Response Elements in Acute Myeloid Leukemia.” Leukemia & Lymphoma 59 (1): 204–13. doi:10.1080/10428194.2017.1324156.